NGM Biopharmaceuticals, Inc. (NGM)
Chart Events
Performance Outlook
| Previous Close | 1.0500 |
| Open | 1.0700 |
| Bid | 1.0400 x 800 |
| Ask | 1.0500 x 1200 |
| Day's Range | 1.0340 - 1.1000 |
| 52 Week Range | 1.0100 - 13.3400 |
| Volume | |
| Avg. Volume | 309,193 |
| Market Cap | 86.851M |
| Beta (5Y Monthly) | 1.16 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.0700 |
| Earnings Date | Nov 01, 2023 - Nov 06, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.67 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for NGM
Related Research
- NGM Biopharmaceuticals, Inc.Daily – Vickers Top Buyers & Sellers for 10/20/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat11 months agoArgus Research
PR NewswireAlexandria Real Estate Equities, Inc.'s One-of-a-Kind, Essential Labspace Platform Empowers the Integration and Enhancement of Biological Discoveries Enabled by AI to Widen the Opportunities for and Accelerate the Development of Novel Medicines
Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science, agtech and advanced technology mega campuses in AAA innovation cluster locations, has been strategically developing and operating high-quality Labspace® infrastructure for, and investing in, some of the most advanced and innovative biopharmaceutical companies leveraging artificial intelligence (AI) and machine learning (ML) platform
ZacksStrength Seen in Repare Therapeutics Inc. (RPTX): Can Its 12.2% Jump Turn into More Strength?
Repare Therapeutics Inc. (RPTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Simply Wall St.Insiders Give Up US$292k As NGM Biopharmaceuticals Stock Drops To US$1.31
Insiders who acquired US$462k worth of NGM Biopharmaceuticals, Inc.'s ( NASDAQ:NGM ) stock at an average price of...
